scispace - formally typeset
M

Maripat Toye

Researcher at Tufts University

Publications -  7
Citations -  579

Maripat Toye is an academic researcher from Tufts University. The author has contributed to research in topics: Nevirapine & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 6, co-authored 6 publications receiving 567 citations.

Papers
More filters
Journal ArticleDOI

Adherence to medication regimens among children with human immunodeficiency virus infection

TL;DR: Caregivers felt that the most helpful interventions would be modifications to improve the convenience and palatability of medications and increased access to medical advice.
Journal ArticleDOI

First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.

Linda Harrison, +496 more
TL;DR: The long-term outcome of protease inhibitor and non-nucleoside reverse transcriptase inhibitor (NNRTI) first-line ART and viral load switch criteria in children with HIV is assessed.
Journal ArticleDOI

Quality of Life for Children and Adolescents: Impact of HIV Infection and Antiretroviral Treatment

Grace M. Lee, +110 more
- 01 Feb 2006 - 
TL;DR: Generally parents of HIV-infected children 6 months to 4 years and 5 to 11 years of age generally reported lower mean QoL scores than did parents of uninfected children, although worse psychological functioning was reported for unin infected children, and no consistent QOL differences among children receiving different antiretroviral regimens.
Journal ArticleDOI

Missed Opportunities for Perinatal HIV Prevention Among HIV-Exposed Infants Born 1996–2000, Pediatric Spectrum of HIV Disease Cohort

Vicki Peters, +98 more
- 01 Sep 2004 - 
TL;DR: Missed opportunities for perinatal HIV prevention contributed to more than half of the cases of HIV-infected infants, and the combination of lack of maternal HIV testing before delivery and lack of prenatal antiretroviral therapies were significantly associated with per inatal HIV transmission.
Journal ArticleDOI

Evidence of human immunodeficiency virus-associated lipodystrophy syndrome in children treated with protease inhibitors.

TL;DR: Children treated with protease inhibitors with HIV-associated lipodystrophy syndrome had higher total cholesterol, higher low density lipoprotein-cholesterol and higher triglycerides than untreated children.